Adam Schechter

Global business leader Adam Schechter became Chief Executive Officer of Labcorp in November 2019 and Chairman of the Board in May 2020. Prior to that, he was named Lead Independent Director in January 2019 after serving as a director of the company since 2013.

Before joining Labcorp, Adam held a variety of senior leadership positions at Merck & Co., Inc. He was Executive Vice President and President of Merck’s Global Human Health Division from 2010 to 2018, leading the company’s worldwide pharmaceutical and vaccine businesses. In this role, he was also a member of Merck’s executive committee.

Prior to becoming President, Global Human Health, Adam served as President of Merck’s global pharmaceutical business from 2007 to 2010. His extensive experience at Merck also included global and U.S.-focused leadership roles spanning sales, marketing and managed markets, as well as business and product development.

Adam has been a Board Member for DaVita Inc. since 2022, and he serves on the Board for Water.org. He also serves as the American Clinical Laboratory Association (ACLA) Board Vice-Chair and a member of the Corporate Advisory Council for the National Alliance for Hispanic Health. Previously, he served on the Boards of the European Federation of Pharmaceutical Industries and Associations (EFPIA), where he led the Policy and Access Committee, the Healthcare Leadership Council and the Merial Animal Health Company.

Adam holds a Bachelor of Science in biology and an honorary doctor of humane letters degree from La Salle University in Philadelphia, Pennsylvania.